Live from the NIH registry
Studies recruiting near Victorville right now
Top 25 of 49 recruiting studies, sorted by proximity — each links to its official registry page
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
National Institute of Clinical Research, Inc — Victorville, California (3.6 mi)
· Sponsor: CSL Behring
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Gaucher Disease, Cerebroside Lipidosis Syndrome
N/A
Observational 12,000 participants sought
Loma Linda University Children'S Hospital- Site Number : 840117 — San Bernardino, California (29.2 mi)
· Sponsor: Genzyme, a Sanofi Company
Evaluating the Impact of Training for IHSS Workers
Home Care for Elderly or Disabled Individuals
N/A
Interventional 2,500 participants sought
San Bernardino County — San Bernardino, California (29.2 mi)
· Sponsor: Abdul Latif Jameel Poverty Action Lab
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Lupus Erythematosus, Systemic, Lupus Nephritis
Phase 2
Interventional 179 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Velocity Clinical Research — San Bernardino, California (29.2 mi)
· Sponsor: vTv Therapeutics
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Boehringer Ingelheim
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Hepatic Impairment, Cirrhosis
Phase 1
Interventional 144 participants sought
Inland Empire Clinical Trials — Rialto, California (29.1 mi)
· Sponsor: Vir Biotechnology, Inc.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Om Research — Victorville, California (3.6 mi)
· Sponsor: Eccogene
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Rialto, California (29.1 mi)
· Sponsor: GlaxoSmithKline
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
SLE (Systemic Lupus), RA - Rheumatoid Arthritis
Phase 1
Interventional 24 participants sought
Carewell Arthritis Center — Apple Valley, California (9.7 mi)
· Sponsor: Neutrolis
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Central Line Associated Blood Stream Infections (CLABSI)
N/A
Interventional 17,800 participants sought
St. Mary Medical Center — Apple Valley, California (9.7 mi)
· Sponsor: Swedish Medical Center
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder, Bleeding Disorder
N/A
Observational 3,000 participants sought
Loma Linda Hemoglobinopathy and Inherited Bleeding Disorder Program — San Bernardino, California (29.2 mi)
· Sponsor: American Thrombosis and Hemostasis Network
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Moderate Hepatic Impairment
Phase 1
Interventional 20 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Site US10008 — San Bernardino, California (29.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
Attention-Deficit/Hyperactivity Disorder (ADHD)
N/A
Interventional 40 participants sought
California State University, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: California State University, San Bernardino
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Proteinuric Kidney Disease
Phase 2, Phase 3
Interventional 466 participants sought
Kidney and Hypertension Center — Victorville, California (3.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Inland Empire Clinical Trials — Rialto, California (29.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Phase 3
Interventional 32,500 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Amgen
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
Functional Constipation (FC)
Phase 2
Interventional 180 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Bausch Health Americas, Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Om Research LLC — Apple Valley, California (9.7 mi)
· Sponsor: Hoffmann-La Roche
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Om Research LLC — Victorville, California (3.6 mi)
· Sponsor: Eli Lilly and Company